The U.S. parenteral nutrition market is expected to register 3.3% CAGR from 2019 to 2025 owing to rise in awareness about various parenteral nutritional products coupled with increasing chronic diseases and healthcare expenses.

Selbyville - May 8, 2019 /MarketersMedia/ —

Child parenteral nutrition segment was valued at over USD 1.8 billion in the year 2018 and will have substantial amount of growth owing to the increasing prevalence of chronic disorders in the babies. Pediatric disorders such asthma, chicken pox, leukemia, tuberculosis, anemia, bronchitis will create high demand for the parenteral nutrition products. Thus, augmenting the growth of the market.

Amino acids market segment is estimated to grow at a CAGR of 3.8% over the projection period. Growing incidence of renal insufficiency, hepatic insufficiency and protein-energy malnutrition will boost the demand of the amino acid-rich parenteral products. Hence, the increasing case of such diseases will propel the growth of the parenteral nutrition market.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3216

The use of parenteral nutrition in hospitals valued around USD 3,155.4 million in the year 2018. Availability of advanced therapeutic solutions in the hospital settings will boost the demand for parenteral nutrition products. Patients suffering from critical medical conditions are mostly in treated in hospitals where they are administered parenteral care, thus presence of state of art facilities in the multi-specialty hospitals and growing popularity of hospitals in developed countries will augment market size over the projection years.

Global Parenteral Nutrition Market is set to surpass USD 5.7 billion by 2025; according to a new research study published by Global Market Insights, Inc. Rising prevalence of chronic diseases such as diabetes in the past few years and increasing trends of malnutrition across the globe primarily drive the demand for various parenteral nutrition products worldwide. Additionally, growing birth rates and increasing incidence of pre-mature births should augment market demand during projection years.

Various government regulatory bodies such as, European Society for Clinical Nutrition and Metabolism and FDA, impose strict government norms in the approval of parenteral nutrition products. As well as, Inadequate infrastructure in developing and under-developed regions acts as a growth hindering factor. Also, lack of awareness among the population of emerging markets happen to hamper adoption rate. Hence, the aforementioned reasons tend to stand as barriers in the parenteral nutrition market growth.

Industry players having a strong foothold include Aculife Healthcare, B. Braun Melsungen AG, Baxter International, Inc. Fresenius Kabi and Grifols International S.A etc. Other notable participants include Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., Guangzhou Green Cross Pharmaceuticals and ICU Medical, etc. To expand their industry presence, many established firms are entering in sparsely addressed high potential regions. Introduction of parenteral solutions in emerging economies by these companies enables them to cater to unmet needs and expand revenue sources.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3216

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Global Market Insights, Inc.
Website: https://www.gminsights.com/pressrelease/parenteral-nutrition-market

Source URL: https://marketersmedia.com/parenteral-nutrition-market-value-will-cross-57-billion-by-2025/510309

Source: MarketersMedia

Release ID: 510309